Low tumor stage (P = 0.004), marked CD8+ (P = 0.04, see Figure 2) and CD57+ (P = 0.05, see Figure 3) cell infiltration in the advancing tumor margin were correlated with a longer disease-free survival in multivariate analysis. This evidence concerns the gene CD8A and neoplasm.